Lukas Beiglboeck

Dr. Lukas Beiglböck

Baker McKenzie Rechtsanwälte LLP & Co KG


Dr. Lukas Beiglböck is an associate in the Dispute Resolution group and member of the Healthcare & Life Sciences and International Commercial & Trade departments in Baker McKenzie’s Vienna office. He joined the Firm in September 2019 and supported the Firm as a trainee in the mentioned fields during his studies in Vienna. Lukas regularly publishes in relevant journals in the Healthcare & Life Sciences sector.

Practice Focus

Healthcare & Life Sciences

The Healthcare & Life Sciences practice focuses on key industries, such as medicinal products (drugs/medicines), medical devices & IVDs, biotechnology, biocidal products, or cosmetics and nutrition. Complementary, the practice covers the healthcare sector, in particular heath care organisations (HCOs) and health care professionals (HCPs).

The main practice focus lies on:

  • Clinical studies and product launches
  • Healthcare compliance, industry codes and ABC
  • Pricing & Reimbursement
  • Life Sciences Regulatory
  • Product promotion and unfair competition practices
  • Business licenses and permits
  • Market authorizations and conformity assessment procedures
  • Distribution and quality contracts
  • Vigilance, product safety and recalls
  • Life Sciences Transactions

International Commercial & Trade

The Commercial & Trade practice focuses on the international sourcing, manufacturing, distributing and selling of products and services, in particular via agency and brokerage models, or by way of distributors, such as authorized dealers or franchise systems. In practice, a crucial aspect are post-termination claims such as indemnities and investment compensations that may have overriding mandatory effect.

Correspondingly, the practice advises on trade compliance related issues such as anti-bribery and corruption, trade sanctions and export and import controls, as well as product labelling, product liability and safety (recalls and preventive measure), and sales promotion and marketing rules across multiple countries.

Another crucial regulatory aspect for engaging in commercial activities are business licenses and permits, such as obtaining the applicable trade licenses and facility permits, and appointing the required regulatory personnel.

In addition, the review and drafting of consumer contracts as well as advising in the course of class actions lodged by consumer associations (e.g., VKI) play an important role.

  • Distribution Contract and Commercial Agreements
  • Business licenses and regulatory permits
  • Consumer contracts
  • Commercial litigation and arbitration
  • Consumer litigation and consumer class actions
  • Trade Compliance


  • University of Vienna (Dr. iur) (2024)
  • University of Vienna (Mag. iur.) (2020)


  • English
  • German

Co-author (with Michaela Petsche and Martina Grama), "Kommen Apps auf Rezept nach Österreich?," Der Standard, 16 February 2024

Co-author (with Daniel Larcher), "Von der – partiellen – Geltung des neuen In-Vitro-Diagnostika-Rechts," ZfG 2022/40

Co-author (with Daniel Larcher), "Zur Entmystifizierung von Medizinproduktebetreiberpflichten," RdM 2022/194

Co-author (with Daniel Larcher), "Das neue Faire-Wettbewerbsbedingungen-Gesetz (FWBG)," ecolex 2022/152

Co-author (with Daniel Larcher), "Das neue österreichische Medizinproduktegesetz 2021," RdM 2021/242

Contributional work to Daniel Larcher, “Investitionsersatz: Rechtsnatur und Differenzersatz," ecolex 2020, 591 ff